Silence Therapeutics Plc Stock Price Prediction
| SLNCF Stock | USD 2.00 0.25 11.11% |
Momentum 69
Buy Stretched
Oversold | Overbought |
Using Silence Therapeutics hype-based prediction, you can estimate the value of Silence Therapeutics plc from the perspective of Silence Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Silence Therapeutics to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Silence because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Silence Therapeutics after-hype prediction price | USD 2.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Silence |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Silence Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Silence Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Silence Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Silence Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Silence Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Silence Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Silence Therapeutics' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Silence Therapeutics' historical news coverage. Silence Therapeutics' after-hype downside and upside margins for the prediction period are 0.10 and 7.52, respectively. We have considered Silence Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Silence Therapeutics is dangerous at this time. Analysis and calculation of next after-hype price of Silence Therapeutics plc is based on 3 months time horizon.
Silence Therapeutics Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Silence Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Silence Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Silence Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.67 | 5.72 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.00 | 2.00 | 0.00 |
|
Silence Therapeutics Hype Timeline
Silence Therapeutics plc is at this time traded for 2.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Silence is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.67%. %. The volatility of related hype on Silence Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 2.00. About 57.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.53. Silence Therapeutics plc had not issued any dividends in recent years. The entity had 1:50 split on the 30th of April 2013. Assuming the 90 days horizon the next forecasted press release will be within a week. Check out Silence Therapeutics Basic Forecasting Models to cross-verify your projections.Silence Therapeutics Related Hype Analysis
Having access to credible news sources related to Silence Therapeutics' direct competition is more important than ever and may enhance your ability to predict Silence Therapeutics' future price movements. Getting to know how Silence Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Silence Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| HNSBF | Hansa Biopharma AB | 0.00 | 0 per month | 0.00 | 0.02 | 0.00 | 0.00 | 89.13 | |
| TRGNF | Transgene SA | 0.00 | 0 per month | 0.00 | 0.09 | 0.00 | 0.00 | 61.69 | |
| SPHDF | Santhera Pharmaceuticals Holding | 0.00 | 0 per month | 0.00 | (0.13) | 0.00 | 0.00 | 27.61 | |
| OPORF | Open Orphan plc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| GNFTF | Genfit SA | 0.00 | 0 per month | 0.00 | 0.07 | 0.00 | 0.00 | 11.29 | |
| MAYNF | Mayne Pharma Group | 0.00 | 1 per month | 0.00 | (0.05) | 10.00 | (9.09) | 46.83 | |
| ORYZF | Oryzon Genomics SA | 0.00 | 0 per month | 0.00 | (0.14) | 0.00 | 0.00 | 22.83 | |
| JWCTF | JW Therapeutics Co | 0.00 | 0 per month | 0.00 | (0.12) | 0.00 | 0.00 | 28.16 | |
| BRIBF | Brii Biosciences Limited | 0.00 | 0 per month | 0.00 | (0.15) | 0.00 | 0.00 | 0.00 | |
| CMVLF | Cellectis SA | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 74.56 |
Silence Therapeutics Additional Predictive Modules
Most predictive techniques to examine Silence price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Silence using various technical indicators. When you analyze Silence charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Silence Therapeutics Predictive Indicators
The successful prediction of Silence Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Silence Therapeutics plc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Silence Therapeutics based on analysis of Silence Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Silence Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Silence Therapeutics's related companies.
Story Coverage note for Silence Therapeutics
The number of cover stories for Silence Therapeutics depends on current market conditions and Silence Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Silence Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Silence Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Complementary Tools for Silence Pink Sheet analysis
When running Silence Therapeutics' price analysis, check to measure Silence Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Silence Therapeutics is operating at the current time. Most of Silence Therapeutics' value examination focuses on studying past and present price action to predict the probability of Silence Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Silence Therapeutics' price. Additionally, you may evaluate how the addition of Silence Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |